Franklin Templeton Investments
Franklin Templeton is one of the world's largest independent investment management organizations, with a history spanning over 75 years. While primarily a public markets asset manager, they participate in select late-stage private investments in healthcare and technology through their Franklin Equity Group and other strategies.
Location
San Mateo, California, USA
Founded
1947
AUM
$1.5T+
Investment Range
$50M - $500M+
Portfolio Companies
1
Focus
generalist
Fund Stages
growth
Investment Thesis
Franklin Templeton participates in select late-stage private company investments and crossover rounds, bringing public market expertise to growth-stage companies. Their healthcare investments focus on precision medicine, digital health, and biotechnology companies approaching public markets.
Team
Partners / Managing Directors (Health & Bio Focus)
- Evan McCulloch, CFA - Senior Vice President, Franklin Equity Group
- Matthew Moberg - Portfolio Manager, Franklin Equity Group
Focus Areas
- Late-stage growth investments
- Public market crossover rounds
- Precision medicine
- Digital health
- Healthcare technology
- Biotechnology
Notable Exits
- Tempus - IPO (2024, precision medicine AI platform)
Sources
- https://www.franklintempleton.com
- https://www.franklintempleton.com/team
- Tempus SEC filings
- PitchBook
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Tempus AI | Chicago, Illinois, USA | 2015 | genomics-sequencingai-drug-discovery+4 |